Today: 10 June 2026
Nebius stock pops near 10% after the close — what traders watch next for NBIS
13 January 2026
1 min read

Nebius stock pops near 10% after the close — what traders watch next for NBIS

New York, Jan 12, 2026, 19:09 EST — After-hours

  • Nebius Group shares climbed roughly 9.6% in late trading, building on Monday’s rally.
  • Shares of AI infrastructure rivals like CoreWeave and IREN also saw gains.
  • Investors eye the next earnings window, seeking updates on financing and capacity.

Nebius Group N.V. shares climbed roughly 9.6% to $107.33 in late Monday trading, after moving between $96.32 and $108.64 earlier in the session. Trading volume hit around 16 million shares.

This shift is significant because the market has rapidly repriced firms renting out AI computing power — and just as swiftly sold off those stocks. Nebius stands out as a clearer proxy for this trade, lacking other factors to soften the volatility.

Monday’s move didn’t come with any new company news. Benzinga suggested the uptick was likely fueled by a stronger mood in tech, rather than a specific Nebius update.

The boost wasn’t limited to one stock. CoreWeave jumped roughly 12%, while IREN climbed over 9%, lifting a group of AI infrastructure names as the session wound down.

Among the bigger players, Oracle gained around 3% and AMD climbed about 2%, though the broader market showed little movement. The Invesco QQQ ETF, which tracks the Nasdaq-100, remained mostly flat.

Nebius offers access to graphics processing units, or GPUs—key chips for training and running AI models—along with software to oversee that workload. Reuters reported in December that the company is expanding beyond large-scale contracts. Co-founder Roman Chernin noted they’re preparing for when “the winter will come.” Reuters

The big contracts continue to dominate the conversation. Reuters reported that Nebius struck a five-year deal to provide Microsoft with GPU infrastructure capacity valued at $17.4 billion. That figure could climb to roughly $19.4 billion if Microsoft opts for extra services.

Nebius hasn’t lost sight of its product plans. Earlier this month, it announced it will start offering Nvidia’s Vera Rubin NVL72 systems in the U.S. and Europe from the second half of 2026. Chief Executive Arkady Volozh said the company is “proud to be one of the first” to roll out the new GPUs.

Still, the optimistic scenario hinges heavily on execution and securing funds. A Microsoft-related SEC filing outlined service-level commitments and “liquidated damages”—meaning preset penalties if capacity arrives late. It also noted that obligations under the agreement kick in only after Nebius confirms it has locked in additional financing for capital expenditures. SEC

In the short term, traders are focused on whether the rally sustains through Tuesday’s regular session and if demand for AI infrastructure stocks continues to pull NBIS along.

The next firm milestone is earnings, though the exact date remains uncertain. Nebius has no events listed on its investor calendar, but MarketBeat projects the report will drop Feb. 18, ahead of market open.

Stock Market Today

  • Asian Stocks Fall as Middle East Tensions Boost Oil Prices
    June 9, 2026, 10:49 PM EDT. Asian stocks declined on Wednesday amid rising tensions in the Middle East, causing uncertainty in global markets. The escalating conflict fueled a surge in oil prices, adding pressure to already heightened inflation concerns. Investors grappled with the prospect of prolonged instability in the region, which has sustained upward momentum in commodity prices over recent months. Traders remain cautious as geopolitical risks continue to overshadow positive economic data.

Latest articles

Nasdaq Sees More Moves After Hours Following U.S. Strike on Iran

Nasdaq Sees More Moves After Hours Following U.S. Strike on Iran

10 June 2026
U.S. stock futures fell after hours and oil rose as U.S. strikes on Iran fueled risk-off sentiment, deepening losses in tech shares and raising investor caution ahead of Wednesday’s key inflation report, with fears of Fed rate hikes and volatility from the upcoming SpaceX IPO adding pressure.
Keel Slides After $458 Million AI Data-Center Debt Deal Launch

Keel Slides After $458 Million AI Data-Center Debt Deal Launch

10 June 2026
Keel Infrastructure shares plunged 4.24% to $5.42 after closing a $458 million convertible debt sale, reviving investor fears of future dilution even as the company boosts funding for AI-focused data-center projects; shares slipped further to $5.32 after hours on more than double average volume, reflecting concerns over execution risks and the impact of new financing.
Super Micro sinks after $7B AI server plan; dilution a risk

Super Micro sinks after $7B AI server plan; dilution a risk

10 June 2026
Super Micro Computer plans to raise $7 billion through equity and equity-linked financing to fund soaring AI server orders, sending shares down about 9% in after-hours trading as investors focused on dilution risk; the company reported $39 billion in recent AI server orders, but noted these are not firm commitments and cited ongoing legal and regulatory risks.
American Airlines Stock Rises on Google Fuel Deal, Market Watches for Fuel Shock

American Airlines Stock Rises on Google Fuel Deal, Market Watches for Fuel Shock

10 June 2026
American Airlines surged to $14.09, up 48.5 cents, after announcing a three-year sustainable aviation fuel deal with Google covering 35 million gallons, as investors focused on surging fuel costs that jumped 78% in April to $6.5 billion; the stock rose in line with airline peers amid a drop in crude prices, while American’s 2026 outlook remains pressured by higher fuel expenses and a narrowed profit forecast.
Nokia Drops 7% After Nvidia 6G Chatter Hits AI Stocks

Nokia Drops 7% After Nvidia 6G Chatter Hits AI Stocks

10 June 2026
Nokia shares plunged 6.99% to 11.970 euros in Helsinki after reports of Nvidia’s push into future mobile-network tech raised fears over Nokia’s AI-driven growth story, with investors questioning whether Nokia can maintain its edge as competition intensifies and its forward P/E more than doubles this year.
Summit Therapeutics stock tumbles as FDA filing for ivonescimab hits tape, GSK trial tie-up follows
Previous Story

Summit Therapeutics stock tumbles as FDA filing for ivonescimab hits tape, GSK trial tie-up follows

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread
Next Story

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread

Go toTop